Advertisement
Singapore markets open in 2 hours 14 minutes

  • Straits Times Index

    3,293.13
    +20.41 (+0.62%)
     

  • S&P 500

    5,071.63
    +1.08 (+0.02%)
     

  • Dow

    38,460.92
    -42.77 (-0.11%)
     

  • Nasdaq

    15,712.75
    +16.11 (+0.10%)
     

  • Bitcoin USD

    64,173.26
    -2,277.47 (-3.43%)
     

  • CMC Crypto 200

    1,388.16
    -35.94 (-2.52%)
     

  • FTSE 100

    8,040.38
    -4.43 (-0.06%)
     

  • Gold

    2,329.10
    -9.30 (-0.40%)
     

  • Crude Oil

    82.82
    +0.01 (+0.01%)
     

  • 10-Yr Bond

    4.6520
    +0.0540 (+1.17%)
     

  • Nikkei

    38,460.08
    +907.92 (+2.42%)
     

  • Hang Seng

    17,201.27
    +372.34 (+2.21%)
     

  • FTSE Bursa Malaysia

    1,571.48
    +9.84 (+0.63%)
     

  • Jakarta Composite Index

    7,174.53
    -7,110.81 (-49.78%)
     

  • PSE Index

    6,572.75
    +65.95 (+1.01%)
     

CryoPort, Inc. (CYRX) Stock Jumps 10.5%: Will It Continue to Soar?

Zacks Equity Research
·2-min read

CryoPort, Inc. (CYRX) shares rallied 10.5% in the last trading session to close at $29.08. This move can be attributable to notable volume with a higher number of shares being traded than in a typical session. This compares to the stock's 8.9% gain over the past four weeks.

This logistics operator, which provides service to other celllular therapy innovators, is being well-served by its growth-by-acquisition approach. The recent deal with Takeda also bodes well. Shares of CYRX  have gained 17.3% over the past month.

This company is expected to post quarterly loss of $0.13 per share in its upcoming report, which represents a year-over-year change of +27.8%. Revenues are expected to be $70.22 million, up 23.9% from the year-ago quarter.

While earnings and revenue growth expectations are important in evaluating the potential strength in a stock, empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock price movements.

ADVERTISEMENT

For CryoPort, Inc., the consensus EPS estimate for the quarter has remained unchanged over the last 30 days. And a stock's price usually doesn't keep moving higher in the absence of any trend in earnings estimate revisions. So, make sure to keep an eye on CYRX going forward to see if this recent jump can turn into more strength down the road.

The stock currently carries a Zacks Rank #3 (Hold). You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>

CryoPort, Inc. is a member of the Zacks Transportation - Services industry. One other stock in the same industry, Matson (MATX), finished the last trading session 0.9% higher at $73.22. MATX has returned 15% over the past month.

For Matson , the consensus EPS estimate for the upcoming report has changed -2.9% over the past month to $6.75. This represents a change of +3.4% from what the company reported a year ago. Matson currently has a Zacks Rank of #3 (Hold).


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
CryoPort, Inc. (CYRX) : Free Stock Analysis Report
 
Matson, Inc. (MATX) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research